Any feedback?
Literature summary for 1.17.4.4 extracted from
- Effects of CYP2C9 and VKORC1 on INR variations and dose rewuirements during initial phase of anticoagulant therapy (2008), Pharmacogenomics, 9, 1237-1250.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | the determination of VKORC1-3 and VKORC1-4 haplotypes may be an important addition to CYP2C9 and VKORC1-2 genotyping to identify patients at risk of being outside the target range during initial anticoagulation with acenocoumarol | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| warfarin | - |
Homo sapiens |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| vitamin K epoxide reductase complex subunit 1 | - |
Homo sapiens |
| VKORC1 | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
